[P1] Poster Session Core Time (Odd no.)

R&D IIIVaccine Science

[P1-83] Development of cCHP nanogel based nasal vaccine for RSV infection.

*Yohei Uchida¹, Shingo Umemoto^1,2, Rika Nakahashi^1,3, Hiroshi Kiyono^1,3,4,5,6,7 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medicine, Oita University (Japan), 3. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine (USA), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (USA), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan))

Password required to view

Log in

or